Home
Home

Facet Biotech

News

Why Biogen Idec Is Likely to Flinch Before Facet Biotech in Their Game of Chicken
BNET Pharma
»

News

Facet Biotech's Board of Directors Recommends Stockholders Continue to Reject Biogen Idec's Tender Offer
Yahoo
»

News

Facet Investors Urged to Deny Offer
Yahoo/Zacks
»

News

Facet Biotech's board recommends shareholders reject Biogen Idec's $356 million tender offer
Yahoo/AP
»

News

Buying binge hits biotech firms
Boston Globe, MA
»

News

Facet advises 'no action' on Biogen bid
Bizjournals.com
»

News

Biogen Idec Makes Bid for Facet for $14.50 a Share
Bloomberg
»

News

Top Facet Investor's Big Sell-Off
InVivo
»

News

Biogen Maintains Facet Offer
Yahoo/Zacks.com
»

News

Why Funds Missed Facet Biotech
Minyanville
»